Growth Metrics

Haemonetics (HAE) Free Cash Flow (2016 - 2025)

Haemonetics has reported Free Cash Flow over the past 17 years, most recently at $87.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 147.63% year-over-year to $87.2 million; the TTM value through Dec 2025 reached $308.1 million, up 211.41%, while the annual FY2025 figure was $142.4 million, 0.82% down from the prior year.
  • Free Cash Flow for Q4 2025 was $87.2 million at Haemonetics, down from $106.3 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $106.3 million in Q3 2025 and troughed at -$33.1 million in Q2 2024.
  • A 5-year average of $32.0 million and a median of $34.1 million in 2022 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: crashed 478.98% in 2021 and later surged 526.93% in 2024.
  • Year by year, Free Cash Flow stood at $22.6 million in 2021, then surged by 110.03% to $47.6 million in 2022, then crashed by 131.93% to -$15.2 million in 2023, then surged by 331.92% to $35.2 million in 2024, then surged by 147.63% to $87.2 million in 2025.
  • Business Quant data shows Free Cash Flow for HAE at $87.2 million in Q4 2025, $106.3 million in Q3 2025, and $13.6 million in Q2 2025.